Transgenic Expression of BCL-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion Injury
Circulation Research - United States
doi 10.1161/01.res.0000143898.67182.4c
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2004
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)